media coverage Archives - Bolt Biotherapeutics

Media Coverage

Bolt Bio Adds $93.5M to Move Ahead Immune-Stimulating Cancer Drugs [...]

By Andrea Tu|2020-11-10T12:12:52-08:00July 7, 2020|media coverage|Comments Off

Piramal Pharma Solutions and Bolt Biotherapeutics Sign Production Agreement ADC [...]

By Andrea Tu|2020-09-09T16:53:43-07:00June 25, 2020|media coverage|Comments Off

U.S. Patent for Bolt Biotherapeutics’ Boltbody™ ISAC Platform Technology is [...]

By Andrea Tu|2020-08-27T17:34:24-07:00June 24, 2020|media coverage|Comments Off

Randall Schatzman, Ph.D. to Lead Growth of Immune- Stimulating Antibody [...]

By Andrea Tu|2020-08-27T17:37:05-07:00June 24, 2020|media coverage|Comments Off

How the Next Generation Antibody Drug Conjugates Expands Beyond Cytotoxic [...]

By Andrea Tu|2020-08-27T17:38:40-07:00June 24, 2020|media coverage|Comments Off

Bolt Biotherapeutics Nabs $93.5M to Push Provenge Inventor's New Idea [...]

By Andrea Tu|2020-08-27T17:40:22-07:00June 23, 2020|media coverage|Comments Off

Bolt’s Myeloid Twist on ADCs Charged up with $93.5M series [...]

By Andrea Tu|2020-08-27T18:04:07-07:00June 22, 2020|media coverage|Comments Off

Pfizer-Backed Bolt Therapeutics Strikes $93.5M Funding Round As Lead Med [...]

By Andrea Tu|2020-08-27T18:04:30-07:00June 22, 2020|media coverage|Comments Off

Agonist ecstasy? HER2 (and more) ‘Bolt’-on strategy draws $93.5M series [...]

By Andrea Tu|2020-08-27T18:04:53-07:00June 22, 2020|media coverage|Comments Off

Bolt Biotherapeutics Initiates Immunotherapy Trial of Lead Drug Candidate in [...]

By Andrea Tu|2020-08-27T18:43:05-07:00March 30, 2020|media coverage|Comments Off